Sun Pharmaceutical Industries Limited has submitted a confirmation certificate for the quarter ended 31 December 2025, as per Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

The certificate was received from M/s. MUFG Intime India Pvt. Ltd., the company's Registrar & Share Transfer Agent. This confirmation pertains to the dematerialization of securities during the quarter. MUFG Intime India Pvt. Ltd. confirmed that securities received from depository participants for dematerialization were processed (accepted/rejected) and subsequently listed on the stock exchanges.

Furthermore, the registrar confirmed that the security certificates received for dematerialization were duly verified, mutilated, and cancelled. The name of the depositories was substituted as the registered owner in the company's register of members within the prescribed timelines. The company noted that no requests for rematerialization were received during this period.